$LXRX

Lexicon Pharmaceuticals Announces Major Agreement with Novo Nordisk for Obesity Drug LX9851

$LXRX Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has entered into an exclusive worldwide licensing agreement with Novo Nordisk A/S, marking a significant…